Dena Zeraatkar

Assistant Professor @MacAnesthesia @HEI_McMaster. Health Research Methodologist/ Epidemiologist. Former @CIHR_IRSC Banting Fellow @HarvardDBMI 🇨🇦👩🏻‍💻

[Dena Zeraatkar @DenaZera]

🎙️Ecstatic to share a podcast interview with @drjohnm from @Sensible__Med about analytic flexibility and nutritional epidemiology.🍎🥩

Hear the podcast: https://t.co/vpUY5tVp3Z
Read the paper: https://t.co/cGwWK8mlWZ

@MacAnesthesia @HEI_mcmaster @machealthsci

[John Mandrola, MD @drjohnm]

You all. I found a beautiful study to write about @Sensible__Med. A new way to analyze observational studies.

Gosh, I am excited. Not only to find this study but also to talk with senior author @DenaZera

Post here https://t.co/vcLCk9UJUO

Podcast tomorrow.

[Dena Zeraatkar @DenaZera]

"A significant fraction of the reporters covering the FDA and pharmaceutical industry have developed, over years of access journalism, a set of relationships and sympathies that align them more closely with the companies they cover than with the regulatory mission"

[Anish Koka, MD @anish_koka]

https://t.co/WXyKfmyS8e

[João Pedro Lima @JoaoPLoboLima]

👁️ Our editorial outlines how ophthalmologists, researchers, and guideline developers can use the GRADE evidence-to-decision (EtD) and the GRADE-Adolopment to create trustworthy clinical practice guidelines.

🔗 Full editorial: https://t.co/YBpDHS5dlo

[Sumanth @Evidentsumanth]

Do you want to reduce your intake of sleeping pills? Check for the latest evidence on what works best from our publication in BMJ: https://t.co/xbJgkowrjv

#benzodiazepines
#sleepingpills
#sedatives
#hypnotics
#deprescription
#CBT
@DenaZera

[The BMJ @bmj_latest]

NEW @bmj_latest research by @DenaZera and colleagues reviews evidence from randomised trials assessing the effectiveness of strategies to deprescribe benzodiazepines and closely related sedative hypnotics
https://t.co/LpCLEHgPnP

[Joshua D. Wallach @JoshuaDWallach]

🚨📢 Postdoc opening @EmoryEPI in pharmaceutical regulation, evidence synthesis & meta-research. 1-year position w/ possible renewal. Formal posting coming soon—message or email me for details. Please share!
@Yale_CRRIT @METRICStanford @NaudetFlorian @RoRInstitute @jsross119

[Dena Zeraatkar @DenaZera]

Super proud of @TylerSC10 ! Amazing work! ⭐️

[Tyler Pitre, MD PhD🇨🇦 @TylerSC10]

🚨 Excited to share our new paper in @LancetRespirMed 🚨
Our systematic review & network meta-analysis compares preoxygenation strategies for critically ill patients needing intubation. NIPPV tops HFNC & facemask in reducing hypoxaemia.

🔍 Study Highlights
• Systematic review & network meta-analysis of 15 RCTs (n=3420)
• Compared HFNC, NIPPV, and facemask oxygen for preoxygenation
• NIPPV likely best at reducing hypoxaemia during intubation
  – vs HFNC: RR 0.73 (moderate certainty)
  – vs facemask: RR 0.51 (high certainty)
• HFNC better than facemask: RR 0.69 (high certainty)
• No strategy improved first-attempt intubation success
• NIPPV may reduce serious adverse events vs HFNC/facemask
• No clear mortality difference between methods
• Data used to inform upcoming international airway guidelines
🧠 Implications: NIPPV may be preferred in high-risk or critically ill patients; findings support evidence-based guideline updates

https://t.co/rlIWdLUzWM

@UofT_DoM @MacDeptMed @Bram_Rochwerg @DenaZera @HEI_mcmaster

[Jason Busse @JasonWBusse]

🚨 New Clinical Guidelines Alert 🚨

A major review recommends against commonly used interventional procedures like epidural injections, nerve blocks & ablations for chronic spine pain

Why? ❌ Similar benefits to sham, potential risks, & high costs

https://t.co/NAhSj0wEPM

[Ophthalmology @AAOjournal]

Face Masking and Risk of Post-Intravitreal Injection Endophthalmitis: A Network Meta-Analysis of 2.6 Million Injections
https://t.co/yh4FQZwDBg
@UofTDOVS @brendantao @RSTHuang @AndrewMihalache @DenaZera @PopovicMM @Jim_SCX @kztoronto @RKohly @RaHMu123

[McMaster Anesthesia @MacAnesthesia]

Enroll now! New term starts January 20th, 2025!

#macanesthesia

[Adam Grant @AdamMGrant]

What leads us to ignore experts isn't their knowledge. It's their arrogance.

Evidence: Scientists are more credible when they admit what they don't know, acknowledge what they got wrong, and update their views.

Trust is earned by expressing humility, not by asserting authority.

[Firstline @Firstline]

🇨🇦 A recent webinar explored how @AMMICanada, @GovCanHealth and @Firstline are partnering to develop evidence-based national antimicrobial prescribing guidelines.

We’re proud to work with these incredible teams, including the AMMI Guidelines Panel: Chair: Dr. @deb_yamamura, Dr. @DenaZera Dr. Mark Loeb, Dr. Nicole Le Saux, Dr. Peter Daley, Dr. @rwittmer3 , Dr. @ATseChangMD , Dr. @BRxAD , Dr. Philippe Morency-Potvin, Dr. Kevin Afra, Dr. Alyssa Ness and Dr. @TimLauRx .

View the full presentation slides here: https://t.co/m10nR9JjSk

[McMaster Health Sciences @machealthsci]

Cognitive behavioral therapy aids patients with long COVID, finds a recently published review from Dena Zeraatkar (@DenaZera), assistant professor @MacAnesthesia and @HEI_mcmaster, and colleagues.

https://t.co/t5Z8KrAh2U

[McMaster Health Sciences @machealthsci]

A new study by researchers with @MacAnesthesia and @HEI_mcmaster has found cognitive behavioural therapy and a program of physical and mental rehab likely improve symptoms of long COVID.

https://t.co/enacwzeoKt

[Dena Zeraatkar @DenaZera]

@HEI_mcmaster @MacAnesthesia @JasonWBusse

[McMaster Health Sciences @machealthsci]

Led by researchers at @McMasterU, a new study suggests that rehabilitation and talk therapies can help reduce long Covid symptoms and that “no compelling evidence supported the effectiveness” of other treatments, including certain drugs or oxygen therapy.

https://t.co/qkgyQj4cGZ

[Roger S. McIntyre, MD, FRCPC @rogersmcintyre]

Recent publication in British Medical Journal BMJ and treatments for long Covid or post Covid condition congratulations to the team

https://t.co/Q6kMZuGtV7

[National Pain Centre @mcmasternpc]

Check out the latest publication from the NPC: Interventions for the management of long covid (post-covid condition): living systematic review
https://t.co/YagIoViuum

[Jason Busse @JasonWBusse]

Our review of interventions for long COVID found that current evidence supports cognitive behavioral therapy, and physical and mental rehabilitation: https://t.co/S3wAudT1XN
@DenaZera

[National Pain Centre @mcmasternpc]

Have you experienced fatigue in the last three months? Pain? Confusion? You may be living with long COVID. Dr. Dena Zeraatkar helps us learn about long COVID and the results of her living systematic review of interventions for the management of long COVID. #NPAW2024

[BMJMedicine @BMJMedicine]

@DenaZera and colleagues address the efficacy and safety of proactive therapeutic drug monitoring of biologic drugs for patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis.

Read the full article here: https://t.co/soDrY26gxD

[Leticia Kawano-Dourado (I'm on BlueSky/LinkedIn) @leticiakawano]

The patient should be at the center of clinical decisions: their values and preferences, not ours.